share_log

Northwest Biotherapeutics (OTCMKTS:NWBO) Shares Cross Below 200-Day Moving Average of $0.74

Defense World ·  Mar 30, 2023 16:04

Northwest Biotherapeutics, Inc. (OTCMKTS:NWBO – Get Rating)'s share price passed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $0.74 and traded as low as $0.60. Northwest Biotherapeutics shares last traded at $0.60, with a volume of 902,059 shares.

Northwest Biotherapeutics Trading Down 4.6 %

The firm has a 50-day moving average of $0.67 and a 200 day moving average of $0.74. The stock has a market capitalization of $644.77 million, a price-to-earnings ratio of -5.96 and a beta of -0.03.

Northwest Biotherapeutics Company Profile

(Get Rating)

Northwest Biotherapeutics, Inc is a biotechnology company, which engages in the development of personalized immune therapies for cancer. It offers DCVax technology platform, which uses activated dendritic cells to mobilize a patient's own immune system to attack their cancer. The company was founded by Alton L.

Featured Stories

  • Get a free copy of the StockNews.com research report on Northwest Biotherapeutics (NWBO)
  • Dave & Buster's Rebound Could Score for Investors
  • Cal-Maine: Is it Time to Chase this Stock Higher?
  • The Most Important Warren Buffett Stock for Investors: His Own
  • Three Mid Caps Wall Street Sees Doubling Within 12 Months
  • It's No Stretch: Lululemon Could Break Out of its Range

Receive News & Ratings for Northwest Biotherapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Northwest Biotherapeutics and related companies with MarketBeat.com's FREE daily email newsletter.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment